
Sign up to save your podcasts
Or


This podcast features a discussion on the need to highlight anhedonia and anergia as core symptoms of depression. We also cover the clinical utility of MAOIs in treating patients with melancholic or biological depression and Parkinson's disease.
Guest: Ken Gillman, M.D.; Interviewer: Wegdan Rashad, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.
By Psychopharmacology Institute4.6
269269 ratings
This podcast features a discussion on the need to highlight anhedonia and anergia as core symptoms of depression. We also cover the clinical utility of MAOIs in treating patients with melancholic or biological depression and Parkinson's disease.
Guest: Ken Gillman, M.D.; Interviewer: Wegdan Rashad, M.D. Hosts: Jessica Diaz, M.D.; Flavio Guzman, M.D.

698 Listeners

76 Listeners

496 Listeners

147 Listeners

302 Listeners

3,344 Listeners

162 Listeners

1,355 Listeners

710 Listeners

556 Listeners

471 Listeners

369 Listeners

717 Listeners

191 Listeners

154 Listeners